Curcumin formulation has been studied in people, and NovaSOL® has a documented bioavailability advantage. Understanding the tested ingredient and its delivery technology helps you connect the research with the formula on a product label.
The human study behind NovaSOL®
In a human crossover study with 23 healthy adults, NovaSOL® liquid micelles showed 185× higher bioavailability than native curcumin powder, measured as total-curcumin exposure over 24 hours (AUC). Schiborr and colleagues used a randomised crossover design, with each participant receiving the compared formulations at a study dose of 500 mg curcuminoids.
The result highlights the role of liquid-micelle technology in curcumin bioavailability. The detailed NovaSOL® evidence guide gives the study design, comparator and measurements in one place.
What different studies explore
| Study type | Research focus | Details to look for |
|---|---|---|
| Laboratory research | How compounds behave in a defined experimental model | The tested material and experimental conditions |
| Human bioavailability study | Absorption and blood exposure after a defined formulation | The formulation, comparator, dose and measurement method |
| Clinical trial | A specified outcome in a defined group of participants | The exact product, participants, duration and measured outcome |
A growing picture of curcumin formulations
Flory and colleagues’ 2021 study directly compared curcumin formulations. Kroon and colleagues’ 2025 crossover study measured total and unconjugated curcumin in nine healthy men and reported the highest uptake with NovaSOL® among the formulations tested. These publications add detail about the formulations and analytical methods used in human absorption research.
For the 185× NovaSOL® comparison, the reported endpoint is total-curcumin exposure over 24 hours. Keeping that measurement alongside the result makes the formulation advantage clear and traceable.
Five useful details in a study
- Ingredient and technology: the exact extract or formulated raw material.
- Dose and duration: the amount tested and the observation period.
- Participants: the people included in the study.
- Comparison and endpoint: what the ingredient was compared with and what was measured.
- Publication details: methods, results, funding, safety reporting and references.
From NovaSOL® research to a daily Licur routine
Licur Max and Licur 7000 both provide 720 mg of the complete NovaSOL® micellar preparation per capsule, with one capsule daily. Licur Max is vegan and has no added vitamin D. Licur 7000 is vegetarian and adds 7.8 µg (312 IU) vitamin D3 from lanolin.
Compare the two Licur formulas to choose the option that fits your dietary preferences and existing supplement routine.
Precautions when using curcumin supplements
ANSES highlights precautions involving bile-duct disorders and possible medicine interactions. Tell your healthcare professional about supplements you use, and do not change treatment because of a study summary or a customer review.
Frequently asked questions
Was NovaSOL® studied in people?
Yes. The published 2014 crossover study involved 23 healthy adults and compared liquid-micelle curcumin with native curcumin powder.
What does the 185× result describe?
It describes the higher bioavailability of the tested liquid-micelle formulation, measured as total-curcumin 24-hour AUC compared with native curcumin powder.
Where can I read the original research?
The primary publications are linked below. Start with Schiborr et al. for the 185× comparison and use the detailed evidence guide for a practical explanation of its measurements.